Patents by Inventor Sven-Borje Andersson
Sven-Borje Andersson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8642627Abstract: Provided are liquid pharmaceutical formulations comprising nicotine in any form for administration essentially to the lungs being acidified and/or alkalized by buffering and/or pH regulation providing for a tmax of nicotine in arterial blood of a subject within a short period of time after administration. The administration is preferably accomplished by spraying an aerosol into the oral cavity for further distribution essentially into the lungs. Methods for manufacturing the formulation is also disclosed, as are uses of the formulation in therapy, such as therapy for treating addiction to tobacco.Type: GrantFiled: June 18, 2010Date of Patent: February 4, 2014Assignee: McNeil ABInventors: Mark P. Warchol, Folke Moren, Kristina Thyresson, Elisabeth Sthengel, Sven-Borje Andersson
-
Publication number: 20100260688Abstract: Provided are liquid pharmaceutical formulations comprising nicotine in any form for administration essentially to the lungs being acidified and/or alkalized by buffering and/or pH regulation providing for a tmax of nicotine in arterial blood of a subject within a short period of time after administration. The administration is preferably accomplished by spraying an aerosol into the oral cavity for further distribution essentially into the lungs. Methods for manufacturing the formulation is also disclosed, as are uses of the formulation in therapy, such as therapy for treating addiction to tobacco.Type: ApplicationFiled: June 18, 2010Publication date: October 14, 2010Inventors: Mark P. Warchol, Folke Morén, Kristina Thyresson, Elisabeth Sthengel, Sven-Börje Andersson
-
Patent number: 7767698Abstract: A liquid pharmaceutical formulation comprising nicotine in any form for administration essentially to the lungs being acidified and/or alkalized by buffering and/or pH regulation providing for a tmax of nicotine in arterial blood of a subject within a short period of time after administration. The administration is preferably by spraying an aerosol into the oral cavity for further distribution essentially into the lungs. A method for manufacturing said formulation. Use of said formulation in therapy, such as therapy for treating addiction to tobacco.Type: GrantFiled: June 2, 2003Date of Patent: August 3, 2010Assignee: McNeil ABInventors: Mark P. Warchol, Folke Morén, Kristina Thyresson, Elisabeth Sthengel, Sven-Börje Andersson
-
Publication number: 20080302375Abstract: The present invention relates to a container comprising nicotine to be inhaled, which is able to retain and release nicotine, and which comprises a shaped mass of fibers and/or filaments. Further, the present invention relates to the use of said container in an inhaling device for obtaining a quick and/or complete reduction of the urge to smoke or use of tobacco and/or for providing a sense of smoking satisfaction without smoking and to the use of said container in smoking cessation therapy.Type: ApplicationFiled: August 18, 2008Publication date: December 11, 2008Applicant: McNeil ABInventors: Sven-Borje Andersson, Bengt Ake Bosson, James Edward Turner, James Peyton Wingo
-
Publication number: 20080286340Abstract: A pharmaceutical oral formulation for delivering nicotine in any form to a subject by transmucosal uptake in the oral cavity comprising nicotine in any form, wherein said oral formulation is buffered with at least one amino acid, preferably at least one endogenous amino acid. Also contemplated is a method for the oral delivery of nicotine in any form, a method for the reduction of the urge to smoke or use tobacco as well as methods for manufacturing the oral formulation, the use of said oral formulation for obtaining transmucosal uptake of nicotine in the oral cavity of a subject, and use of nicotine for the production of an oral formulation as per above for the treatment of a disease selected from the group consisting of tobacco or nicotine dependence, Alzheimer's disease, Crohn's disease, Parkinson's disease, Tourette's syndrome, ulcerous colitis and post-smoking-cessation weight control.Type: ApplicationFiled: May 16, 2007Publication date: November 20, 2008Inventors: Sven-Borje Andersson, Gunnar Bergengren, Bengt Bosson, Andreas Hugerth, Fredrik Nicklasson, Roland Olsson
-
Publication number: 20080286341Abstract: Coated oral dosage forms for the delivery of nicotine in any form to a subject by rapid intraoral delivery of nicotine comprising at least one core, nicotine in any form and/or a nicotine mimicking agent, at least one coating layer and optionally at least one or more other additives, wherein said at last one coating layer is buffered, whereby is used at least one amino acid as buffering agent. Also contemplated are a method for the delivery of nicotine in any form, a method for the reduction of the urge to smoke or use tobacco as well as a method for producing said coated product and use of the same for obtaining a rapid intraoral uptake of nicotine.Type: ApplicationFiled: May 16, 2007Publication date: November 20, 2008Inventors: Sven-Borje Andersson, Gunnar Bergengren, Bengt Bosson, Andreas Hugerth, Fredrik Nicklasson, Roland Olsson
-
Publication number: 20050053665Abstract: Nicotine-containing pharmaceutical compositions wherein nicotine is absorbed into and/or adsorbed onto cellulose of non-seed organism origin, especially cellulose from algae, bacteria and/or fungi.Type: ApplicationFiled: September 7, 2004Publication date: March 10, 2005Inventors: Ragnar Ek, Albert Mihranyan, Sven-Borje Andersson, Bengt Bosson, Nils-Olof Lindberg
-
Publication number: 20040182403Abstract: The present invention relates to a container comprising nicotine to be inhaled, which is able to retain and release nicotine, and which comprises a shaped mass of fibers and/or filaments. Further, the present invention relates to the use of said container in an inhaling device for obtaining a quick and/or complete reduction of the urge to smoke or use of tobacco and/or for providing a sense of smoking satisfaction without smoking and to the use of said container in smoking cessation therapy.Type: ApplicationFiled: February 20, 2004Publication date: September 23, 2004Inventors: Sven-Borje Andersson, Bengt Ake Bosson, James Edward Turner, James Peyton Wingo
-
Publication number: 20040034068Abstract: A liquid pharmaceutical formulation comprising nicotine in any form for administration essentially to the lungs being acidified and/or alkalized by buffering and/or pH regulation providing for a tmax of nicotine in arterial blood of a subject within a short period of time after administration.Type: ApplicationFiled: June 2, 2003Publication date: February 19, 2004Applicant: WOODCOCK WASHBURN LLPInventors: Mark P. Warchol, Folke Moren, Kristina Thyresson, Elisabeth Sthengel, Sven-Borje Andersson
-
Patent number: 6676959Abstract: Formulations of nicotine for use in nicotine replacement therapy. The formulations are intended for application in the oral cavity where upon the uptake of nicotine mainly takes place through the buccal mucosa. The formulations essentially comprise apolar, polar and surface-active components. The formulations may be administered in combination with other nicotine formulations.Type: GrantFiled: July 11, 2001Date of Patent: January 13, 2004Assignee: Pharmacia ABInventors: Sven Börje Andersson, Tomas Landh, Stefan Jonn, Stefan Grudén, Nils-Olof Lindberg
-
Patent number: 6098632Abstract: The present invention relates to a nicotine-impermeable container and a method for fabricating same. Additionally, the invention relates to a nicotine inhaling device which allows a user to ingest nicotine vapors orally. The nicotine inhaling device of the present invention is primarily directed to a device which can be used as a smoking cessation aid.Type: GrantFiled: February 20, 1997Date of Patent: August 8, 2000Assignee: Pharmacia & Upjohn ABInventors: James E. Turner, Michael P. Ellis, Ronald G. Oldham, Ira Hill, Bengt Eber Malmborg, Sven-Borje Andersson
-
Patent number: 5400808Abstract: The present invention relates to a nicotine-impermeable container including a barrier layer of acrylonitrile and methyl acrylate and a method for fabricating same. Additionally, the invention relates to a nicotine inhaling device which allows a user to ingest nicotine vapors orally. The nicotine inhaling device of the present invention is primarily directed to a device which can be used as a smoking cessation aid.Type: GrantFiled: November 25, 1992Date of Patent: March 28, 1995Assignee: Pharmacia Biosystems AktiebolagInventors: James E. Turner, Michael P. Ellis, Ronald G. Oldham, Ira Hill, Bengt E. Malmborg, Sven-Borje Andersson
-
Patent number: 5188835Abstract: The invention concerns an intravaginal device comprising a combination of 17.beta.-estradiol and a supporting matrix for treating hypoestrogenic women. The device releases continously 17.beta.-estradiol at a rate of about 0.5 to about 25 .mu.g/24 h. The invention also comprises a method of preparing the device and a method of treating hypoestrogenic women by using the device.Type: GrantFiled: November 12, 1991Date of Patent: February 23, 1993Assignee: Kabi Pharmacia ABInventors: Inga M. Lindskog, Bengt C. H. Sjogren, Sven-Borje Andersson
-
Patent number: 5167242Abstract: The present invention relates to a nicotine-impermeable container and a method for fabricating same. Additionally, the invention relates to a nicotine inhaling device which allows a user to ingest nicotine vapors orally. The nicotine inhaling device of the present invention is primarily directed to a device which can be used as a smoking cessation aid.Type: GrantFiled: June 8, 1990Date of Patent: December 1, 1992Assignee: Kabi Pharmacia AktiebolaqInventors: James E. Turner, Michael P. Ellis, Ronald G. Oldham, Ira Hill, Bengt E. Malmborg, Sven-Borje Andersson
-
Patent number: 4871543Abstract: The invention concerns an intravaginal device comprising a combination of 17 .beta.-estradiol and a supporting matrix for treating hypoestrogenic women. The device releases continuously 17 .beta.-estradiol at a rate of about 0.5 to about 25 .mu.g/24 h.The invention also comprises a method of preparing the device and a method of treating hypoestrogenic women by using the device.Type: GrantFiled: June 12, 1987Date of Patent: October 3, 1989Assignee: Aktiebolaget LeoInventors: Inga M. Lindskog, Bengt C. H. Sjogren, Sven-Borje Andersson